Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells

Jaemoo Chun(Korea Institute of Oriental Medicine), Yeong Shik Kim(Seoul National University), Dong‐Ung Lee(Dongguk University), Salman Khan(Roswell Park Comprehensive Cancer Center), Dong‐Sung Lee(Chosun University), Ran Joo Choi(Yonsei University), Young-Joo Nam(Dongguk University), Youn‐Chul Kim(Sungkyunkwan University)
International Immunopharmacology
August 28, 2012
Cited by 184


Related Papers